Retagliptin
Retagliptin Uses, Dosage, Side Effects, Food Interaction and all others data.
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
| Trade Name | Retagliptin |
| Generic | Retagliptin |
| Type | |
| Formula | C19H18F6N4O3 |
| Weight | Average: 464.368 Monoisotopic: 464.128309434 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Retagliptin
